글로벌 자가면역 치료 시장 – 2028년까지의 산업 동향 및 예측

글로벌 자가면역 치료 시장 분석 및 통찰력

자가면역 치료 시장은 2021년에서 2028년의 예측 기간 동안 시장 성장을 이룰 것으로 예상됩니다. Data Bridge Market Research는 위에서 언급한 예측 기간 동안 시장이 3.8%의 CAGR로 성장할 것으로 분석합니다. 의료 분야에 대한 인식 증가가 자가면역 치료 시장을 주도합니다.

자가면역 질환은 신체의 면역 체계가 건강한 신체 세포를 이물질 세포로 인식하고, 면역 체계가 감염성 물질이 아닌 신체의 건강한 조직을 공격하고 파괴하는 자가 항체를 생성할 때 발생합니다. 이 질병은 신체에 정상적으로 존재하는 물질과 조직에 대한 과잉 면역 반응이며, 이는 일반적으로 유전적, 감염적 또는 환경적 요인에 의해 발생합니다. 이는 비정상적인 장기 성장과 장기 기능의 변화로 이어질 수 있습니다.

제약 및 생명 과학 분야에서 R&D에 대한 투자를 늘리는 것은 시장 성장을 가속화하는 중요한 요인이며, 다양한 치료 대안의 가용성 증가, 소비자들 사이에서 자가면역 질환에 대한 인식 증가, 대규모 환자 기반, 의료비 증가, 연구 개발 활동 증가는 자가면역 치료 시장을 주도하는 주요 요인입니다. 게다가 의료 기기의 기술적 진보와 현대화 증가, 신흥 경제권의 수요 증가는 2021-2028년 예측 기간 동안 자가면역 치료 시장에 새로운 기회를 창출할 것입니다.

그러나 숙련된 기술자의 부족과 다양한 자가면역 질환의 기본 병인에 대한 이해 부족은 시장 성장을 방해하는 주요 요인으로 작용하고, 위에서 언급한 예측 기간 동안 자가면역 치료 시장 성장에 더욱 어려움을 겪을 것입니다.

The autoimmune treatment market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the autoimmune treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Autoimmune Treatment Market Scope and Market Size

• The autoimmune treatment market is segmented on the basis of product type, disease type and service type. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
• On the basis of product type, the autoimmune treatment market is segmented into drugs, diagnostic equipment and therapeutic and monitoring equipment.
• Based on disease type, the autoimmune treatment market is segmented into systemic autoimmune diseases and localized autoimmune diseases. Systemic autoimmune diseases have been further segmented into lupus, psoriasis, rheumatoid arthritis (RA) and others. Others have been further sub segmented into juvenile arthritis, scleroderma, ankylosing and spondylitis. Localized autoimmune diseases have been further segmented into type I diabetes, thyroid disease, multiple sclerosis (MS), inflammatory bowel disease (IBD) and other. Other has been further sub segmented into multiple sclerosis, myasthenia gravis and primary biliary cirrhosis.
• The autoimmune treatment market is also segmented on the basis of service type into consultation and diagnosis, therapy and monitoring and drug development.

Global Autoimmune Treatment Market Country Level Analysis

The autoimmune treatment market is analysed and market size insights and trends are provided by country, product type, disease type and service type as referenced above.

The countries covered in the autoimmune treatment market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the autoimmune treatment market due to rise in the availability of various alternatives for treatment, rise in the awareness about autoimmune diseases among consumers and large patient base in this region. Asia-Pacific is the expected region in terms of growth in autoimmune treatment market due to rise in the availability of various alternatives for treatment, rise in the awareness about autoimmune diseases among consumers and large patient base in this region.

The country section of the autoimmune treatment market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

The autoimmune treatment market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment’s, installed base of different kind of products for autoimmune disease treatment market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the autoimmune disease treatment market. The data is available for historic period 2010 to 2019.

Competitive Landscape and Global Autoimmune Treatment Market Share Analysis

The autoimmune treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to autoimmune treatment market.

자가면역 치료 시장 보고서에서 다루는 주요 기업은 Autoimmune Inc, Siemens Healthcare Private Limited, LUPIN., Thermo Fisher Scientific Inc, Beckman Coulter, Inc, Chugai Pharmaceutical Co., Ltd., GlaxoSmithKline plc, Biogen, Bayer AG, Genentech, Inc, Merck Sharp & Dohme Corp, Bristol-Myers Squibb Company, AstraZeneca, F. Hoffmann-La Roche Ltd, Pfizer Inc., Eli Lilly and Company, Johnson & Johnson Services, Inc., Amgen Inc, Abbott 등 국내 및 글로벌 기업입니다. 시장 점유율 데이터는 글로벌, 북미, 유럽, 아시아 태평양(APAC), 중동 및 아프리카(MEA), 남미에 대해 개별적으로 제공됩니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁자에 대한 경쟁 분석을 개별적으로 제공합니다.

SKU-23966